about
A High-grade Sarcoma Arising in a Patient With Recurrent Benign Giant Cell Tumor of the Proximal Tibia While Receiving Treatment With DenosumabSinomenine suppresses osteoclast formation and Mycobacterium tuberculosis H37Ra-induced bone loss by modulating RANKL signaling pathwaysEffects of antibody to receptor activator of nuclear factor κ-B ligand on inflammation and cartilage degradation in collagen antibody-induced arthritis in mice.Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis.Associations between Systemic Markers of Bone Turnover or Bone Mineral Density and Anti-Resorptive Agent-Related Osteonecrosis of the Jaw in Patients Treated with Anti-Resorptive Agents.Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.Pathophysiology of Osteonecrosis of the Jaws.Osteoporosis in chronic inflammatory disease: the role of malnutrition.The role of osteoprotegerin in cardiovascular disease.Osteoporosis in men: recent progress.Prevalence of osteoporosis in prostate cancer survivors: a meta-analysis.The inhibition of RANK-ligand in the management of postmenopausal osteoporosis and related fractures: the role of denosumab.Alternative pathways of osteoclastogenesis in inflammatory arthritis.Transcriptional network systems in cartilage development and disease.Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome.
P2860
Q27000565-8E4C55D8-4862-4903-81FF-DE243DD146D8Q28533497-FF456B04-2AF3-4F67-AE8E-335463DC90DAQ34746798-5C28E7E6-0B0C-482E-A588-50C522D22FBDQ36065421-1ACE1860-5B5C-45E7-8FAB-8A6FE5A5310BQ36753894-322026C8-D22B-477D-81FE-3499F9834201Q36945036-C97C4676-0292-42A2-A514-E964BAE4D051Q37006852-DB1F417D-4BED-4475-B11A-25DA7D72F4B0Q38051265-3ECE3FDE-889D-4F80-8AB0-7D87B0829009Q38056541-45B19B07-AB39-47DA-B398-E45A3C4A77E5Q38077109-D21009AA-2912-47BE-BA5B-84AEF70B33F3Q38156703-77FCD8DE-2F6F-4AE7-A81F-C8CC1EC9DA3DQ38193181-2A37B0A3-42A8-429C-8A72-ACE3276B4B5CQ38271156-E19F18B9-8F92-4B1C-A320-3F42EA6406E0Q47225671-31E0BFFC-11F7-4633-BE73-8046ACB01771Q51345508-51E3E7FB-44DE-419A-8FC5-0A2AF6108DAF
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Skeletal and extraskeletal actions of denosumab.
@en
type
label
Skeletal and extraskeletal actions of denosumab.
@en
prefLabel
Skeletal and extraskeletal actions of denosumab.
@en
P2093
P2860
P1433
P1476
Skeletal and extraskeletal actions of denosumab
@en
P2093
Christine Hamann
Elena Tsourdi
Kathrin Sinningen
Martina Rauner
Tilman D Rachner
P2860
P2888
P356
10.1007/S12020-012-9696-X
P577
2012-05-13T00:00:00Z